If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...
This month, Neuvivo submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for NP001 (sodium chlorite infusion). The drug has been granted orphan drug and fast track ...
and a rise to 10.8 per cent from 9 per cent on sodium chlorite, a chemical compound used in pulp and paper processing. Additional duties target metal foils, nebulisers, titanium dioxide pigments ...
Sable Resources Ltd. ("Sable" or the "Company") (TSXV:SAE | OTCQB:SBLRF) is pleased to announce that it has received additional positive surface results from its 100% owned Copper Queen Project in ...
Dr. Ruben Padilla, President and CEO of Sable stated, “We are extremely pleased with the composite results of our 2024 field season. Breccias 1, 2, and 3 and the surrounding area is becoming a ...
Drill holes HER-24-19 through -21 begin in shallow phyllic alteration associated with the enrichment blanket and transition with depth into varying degrees of biotite alteration consistent with an ...
Neuvivo has submitted a New Drug Application (NDA) for its investigational amyotrophic lateral sclerosis (ALS) immunotherapy to the US Food and Drug Administration (FDA). Neuvivo hopes its ...